Phytochemical Name : Xanthomicrol

Properties Information
PhytoCAT-ID PhytoCAT-417
Phytochemical name or plant extracts Xanthomicrol
PMID 33217075
Literature evidence Our data demonstrated that xanthomicrol can induce apoptosis and suppress angiogenesis in breast cancer cells due to its inhibitory effect on oncomirs and its stimulatory effect on tumor suppressor miRNAs. © 2020 John Wiley & Sons Ltd.
IUPAC name 5-hydroxy-2-(4-hydroxyphenyl)-6,7,8-trimethoxychromen-4-one
Phytochemicals’ class or type of plant extracts Flavonoid
Source of phytochemicals or plant Extracts Sideritis leucantha
Geographical availability Spain
Plant parts NA
Other cancers Breast cancer
Target gene or protein TNF-α, VEGF, MMP9, Ki67, Bax, Caspase 3, Caspase 9, miR21, miR27, miR125, miR29, miR34
Gene or Protein evidence In addition, xanthomicrol reduced the expression of TNFα, VEGF, MMP9, and Ki67, while upregulating the expression of apoptotic markers such as Bax, caspase3, and caspase9. Finally, the expression of miR21, miR27, and miR125, known as oncomirs, decreased significantly after xanthomicrol administration, while the expression of miR29 and miR34, functioning as tumor suppressors, increased significantly (p < .001).
Target pathways NA
IC50 35 μg/ml against 4T1
Potency These data showed that the IC50 concentration of xanthomicrol could increase the percentage of both early and late apoptotic cells. The total apoptotic rate (Q2 + Q3) showed a 2.7-fold increase compared with the untreated group
Cell line/ mice model 4T1, Mouse fibroblast cells
Additional information  Finally, the expression of miR21, miR27, and miR125, known as oncomirs, decreased significantly after xanthomicrol administration, while the expression of miR29 and miR34, functioning as tumor suppressors, increased significantly (p < .001)
PubChem ID 73207
Additional PMIDs 34215226
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:458973-1
Safety NA